Level of maternal antibodies against respiratory syncytial virus (RSV) nucleoprotein at birth and risk of RSV very severe lower respiratory tract infection.

Matthieu Receveur Michèle OttmannJean-Marc ReynesJean-François Eleouet Marie Galloux Aurore Receveur Dominique PloinSylvie FioriniNathalie RivatMartine ValetteBruno Lina Jean-Sebastien Casalegno

Published in: Influenza and other respiratory viruses (2022)

Further studies are needed to support the hypothesis that transfer of maternal antibodies against the RSV N protein can provide a significant immune protection early in infancy and that N protein candidate vaccine may be a suitable target for maternal vaccine.

Keyphrases

respiratory syncytial virus
respiratory tract
birth weight
pregnancy outcomes
gestational age
weight gain
protein protein
pregnant women
small molecule
physical activity
drug induced
electron transfer